Yu Feng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yu Feng has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Stephen I. Alexander
Department of Pediatric Nephrology, The Children's Hospital at Westmead and Centre for Kidney Research, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia
2 shared publications - Xiangjian Zheng
Department of Pharmacology and Tianjin Key Laboratory of Inflammation Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China
2 shared publications - Yanmiao Qi
Department of Pharmacology, Tianjin Key Laboratory of Inflammation Biology, Center for Cardiovascular Diseases, School of Basic Medical Sciences, The Province and Ministry Co-Sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Medical University, Tianjin, China
2 shared publications - Yin Xia
School of Biomedical Sciences, Faculty of Medicine; GIBH CAS-CUHK Joint Research Laboratory on Stem Cell and Regenerative Medicine, The Chinese University of Hong Kong
2 shared publications - Angela Tamsin Morgan
Murdoch Children’s Research Institute, Royal Children’s Hospital, Parkville, Australia
1 shared publication Dongbo Lu
Department of Pharmacology and Tianjin Key Laboratory of Inflammation Biology, School of Basic Medical Sciences, and Center for Cardiovascular Diseases, Tianjin Medical University, Tianjin, China
1 shared publication
Latest Publications
- 6 October 2025
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 37 (4) , 669-682
Hmx2 and Dmrt2 Coordinate the Differentiation of Intercalated Cell Subtypes in Kidney
Key Points: Hmx2 was required for type B intercalated cell differentiation but became dispensable in the absence of Dmrt2. Dmrt2 promoted type A differentiation of intercalated cells and repressed type B identity. Early divergence of Dmrt2 and Hmx2 marked subtype specification of intercalated cells. Background: Intercalated cells in the kidney collecting ducts are essential for maintaining systemic acid–base homeostasis. Based on gene expression profiles and functional characteristics, intercalated cells are classified into type A, type B, non-A/non-B. Although several transcription factors have been reported to regulate intercalated cell differentiation, how the fates of intercalated cell subtypes are established remains unclear. Methods: To investigate the roles of Dmrt2 and Hmx2 in intercalated cell subtype differentiation, we generated mice with single or double conditional deletion and knock-in of these transcription factors specifically in distal nephron segments and analyzed their effects on urine acidification. We also performed single-cell RNA sequencing analysis on mouse and human kidney datasets to trace intercalated cell progenitor fate trajectories. Results: Loss of Hmx2 in the distal nephron prevented type B intercalated cell differentiation, whereas simultaneous deletion of Hmx2 and Dmrt2 compromised type A intercalated cell differentiation, with a concomitant increase in Hmx3 expression and type B intercalated cell differentiation. Dmrt2 knock-in mice exhibited a modest increase in type A intercalated cell differentiation and a marked reduction in type B intercalated cells. Notably, Dmrt2 knock-in did not rescue the intercalated cell differentiation defects observed in Foxp1-deficient mice. Analysis of mouse and human single-cell RNA sequencing data further confirmed the mutually exclusive expression patterns of Hmx2 and Dmrt2 in the kidney. Conclusions: Hmx2 and Dmrt2 were essential, mutually exclusive transcription factors that govern intercalated cell subtype differentiation in the kidney, with Hmx2 specifying type B intercalated cell fate and Dmrt2 promoting type A intercalated cell differentiation. Dmrt2 suppressed the expression of Hmx2 and Hmx3. In the absence of Dmrt2 and Hmx2, Hmx3 expression was activated to promote type B intercalated cell differentiation.
- 6 October 2025
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 37 (4) , 669-682
Hmx2 and Dmrt2 Coordinate the Differentiation of Intercalated Cell Subtypes in Kidney
Key Points: Hmx2 was required for type B intercalated cell differentiation but became dispensable in the absence of Dmrt2. Dmrt2 promoted type A differentiation of intercalated cells and repressed type B identity. Early divergence of Dmrt2 and Hmx2 marked subtype specification of intercalated cells. Background: Intercalated cells in the kidney collecting ducts are essential for maintaining systemic acid–base homeostasis. Based on gene expression profiles and functional characteristics, intercalated cells are classified into type A, type B, non-A/non-B. Although several transcription factors have been reported to regulate intercalated cell differentiation, how the fates of intercalated cell subtypes are established remains unclear. Methods: To investigate the roles of Dmrt2 and Hmx2 in intercalated cell subtype differentiation, we generated mice with single or double conditional deletion and knock-in of these transcription factors specifically in distal nephron segments and analyzed their effects on urine acidification. We also performed single-cell RNA sequencing analysis on mouse and human kidney datasets to trace intercalated cell progenitor fate trajectories. Results: Loss of Hmx2 in the distal nephron prevented type B intercalated cell differentiation, whereas simultaneous deletion of Hmx2 and Dmrt2 compromised type A intercalated cell differentiation, with a concomitant increase in Hmx3 expression and type B intercalated cell differentiation. Dmrt2 knock-in mice exhibited a modest increase in type A intercalated cell differentiation and a marked reduction in type B intercalated cells. Notably, Dmrt2 knock-in did not rescue the intercalated cell differentiation defects observed in Foxp1-deficient mice. Analysis of mouse and human single-cell RNA sequencing data further confirmed the mutually exclusive expression patterns of Hmx2 and Dmrt2 in the kidney. Conclusions: Hmx2 and Dmrt2 were essential, mutually exclusive transcription factors that govern intercalated cell subtype differentiation in the kidney, with Hmx2 specifying type B intercalated cell fate and Dmrt2 promoting type A intercalated cell differentiation. Dmrt2 suppressed the expression of Hmx2 and Hmx3. In the absence of Dmrt2 and Hmx2, Hmx3 expression was activated to promote type B intercalated cell differentiation.
- 9 February 2024
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 35 (5) , 533-548
Foxp1 Is Required for Renal Intercalated Cell Differentiation and Acid–Base Regulation
Key Points: Foxp1 is a key transcriptional factor for the differentiation of intercalated cells in collecting ducts. Dmrt2 and Hmx2 act downstream of Foxp1 to control the differentiation of type A and type B intercalated cells, respectively. Foxp1 and Dmrt2 are essential for body acid–base balance regulation. Background: Kidney collecting ducts comprise principal cells and intercalated cells, with intercalated cells playing a crucial role in kidney acid–base regulation through H+ and HCO3 − secretion. Despite its significance, the molecular mechanisms controlling intercalated cell development remain incompletely understood. Methods: To investigate the specific role of Foxp1 in kidney tubular system, we specifically deleted Foxp1 expression in kidney distal nephrons and collecting ducts. We examined the effects of Foxp1 on intercalated cell differentiation and urine acidification. RNA sequencing and Chip-seq were used to identify Foxp1 target genes. To dissect the genetic network that regulates intercalated cell differentiation, Dmrt2-deficient mice were generated to determine the role of Dmrt2 in intercalated cell differentiation. Foxp1-deficient mice were crossed with Notch2-deficient mice to dissect the relation between Foxp1 and Notch signaling. Results: Foxp1 was selectively expressed in intercalated cells in collecting ducts. The absence of Foxp1 in kidney tubules led to the abolishment of intercalated cell differentiation in the collecting ducts, resulting in distal renal tubular acidosis. Foxp1 regulates the expression of Dmrt2 and Hmx2, two genes encoding transcription factors specifically expressed in type A and type B intercalated cell cells, respectively. Further genetic analysis revealed that Dmrt2 was essential for type A intercalated cell differentiation, and Foxp1 was necessary downstream of Notch for the regulation of intercalated cell differentiation. Conclusions: Foxp1 is required for the renal intercalated cell differentiation and participated in acid–base regulation. Foxp1 regulated downstream transcriptional factors, Dmrt2 and Hmx2, which were involved in the specification of distinct subsets of intercalated cells.
- 9 February 2024
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 35 (5) , 533-548
Foxp1 Is Required for Renal Intercalated Cell Differentiation and Acid–Base Regulation
Key Points: Foxp1 is a key transcriptional factor for the differentiation of intercalated cells in collecting ducts. Dmrt2 and Hmx2 act downstream of Foxp1 to control the differentiation of type A and type B intercalated cells, respectively. Foxp1 and Dmrt2 are essential for body acid–base balance regulation. Background: Kidney collecting ducts comprise principal cells and intercalated cells, with intercalated cells playing a crucial role in kidney acid–base regulation through H+ and HCO3 − secretion. Despite its significance, the molecular mechanisms controlling intercalated cell development remain incompletely understood. Methods: To investigate the specific role of Foxp1 in kidney tubular system, we specifically deleted Foxp1 expression in kidney distal nephrons and collecting ducts. We examined the effects of Foxp1 on intercalated cell differentiation and urine acidification. RNA sequencing and Chip-seq were used to identify Foxp1 target genes. To dissect the genetic network that regulates intercalated cell differentiation, Dmrt2-deficient mice were generated to determine the role of Dmrt2 in intercalated cell differentiation. Foxp1-deficient mice were crossed with Notch2-deficient mice to dissect the relation between Foxp1 and Notch signaling. Results: Foxp1 was selectively expressed in intercalated cells in collecting ducts. The absence of Foxp1 in kidney tubules led to the abolishment of intercalated cell differentiation in the collecting ducts, resulting in distal renal tubular acidosis. Foxp1 regulates the expression of Dmrt2 and Hmx2, two genes encoding transcription factors specifically expressed in type A and type B intercalated cell cells, respectively. Further genetic analysis revealed that Dmrt2 was essential for type A intercalated cell differentiation, and Foxp1 was necessary downstream of Notch for the regulation of intercalated cell differentiation. Conclusions: Foxp1 is required for the renal intercalated cell differentiation and participated in acid–base regulation. Foxp1 regulated downstream transcriptional factors, Dmrt2 and Hmx2, which were involved in the specification of distinct subsets of intercalated cells.